# Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction

> **NCT06511232** · PHASE4 · RECRUITING · sponsor: **The Methodist Hospital Research Institute** · enrollment: 84 (estimated)

## Conditions studied

- Anterior Cruciate Ligament Tear
- Anterior Cruciate Ligament Injuries
- Anterior Cruciate Ligament Rupture

## Interventions

- **DRUG:** Intraosseous Morphine

## Key facts

- **NCT ID:** NCT06511232
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-19
- **Primary completion:** 2027-07-31
- **Final completion:** 2029-07-31
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06511232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06511232, "Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06511232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*